RAB21

Across TCGA pan-cancer cohorts, RAB21 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated RAB21 data layer compared with 18 for mass-spec protein and 8 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RAB21 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated RAB21 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

HNSC and UCEC are the cancer types where RAB21 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.199	0.768	.002	42	view →
UCEC	DFS	Median	II,III,IV	1.000	0.487	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

RAB21–HNSC (OS)

Open the HNSC breakdown →